FAF1胚系突变与遗传性结直肠癌相关
研究对40个结直肠癌家族中75例患者行全外显子测序,发现FAF1基因致病变异(c.1111G>A;p.Asp371Asn),并在473个家族的外部验证队列中鉴定出第二个FAF1变异(c.254G>C;p.Arg85Pro)。两个变异均编码不稳定FAF1蛋白,在结直肠癌细胞中导致凋亡抵抗、β-catenin胞质积聚及NF-κB核转位。
要点
- FAF1胚系变异(c.1111G>A;p.Asp371Asn)在40个结直肠癌家族中发现,同一家族4例患者携带。
- 外部验证队列473个家族中鉴定出第二个FAF1变异(c.254G>C;p.Arg85Pro)。
- 两个FAF1变异均编码不稳定蛋白,使结直肠癌细胞抗凋亡并激活β-catenin和NF-κB。
核心结论
- 在遗传性结直肠癌家族中鉴定出FAF1基因变异,这些变异编码不稳定FAF1蛋白,增加结直肠癌细胞凋亡抵抗并增强β-catenin和NF-κB活性。
研究设计与样本
- 发现队列:对40个有结直肠癌病史(含早发)且胚系基础不明的家族中75例患者行全外显子测序。
- 验证队列:对473个家族(含488例错配修复蛋白表达正常的结直肠肿瘤患者)的DNA行特定基因测序。
- 功能实验:用CRISPR/Cas9在DLD-1结直肠癌细胞中敲除FAF1,并转染表达FAF1错义变异的质粒,行免疫印迹、定量实时PCR及凋亡、增殖、Wnt信号和NF-κB活性功能测定。
主要发现
- 发现队列中鉴定出FAF1预测致病变异c.1111G>A(p.Asp371Asn),同一家族4例患者携带。
- 验证队列中鉴定出第二个FAF1变异c.254G>C(p.Arg85Pro)。
- 两个变异均编码不稳定FAF1蛋白。
- 在结直肠癌细胞中表达这些变异导致细胞抗凋亡、β-catenin在胞质积聚、NF-κB转位至细胞核。
关键数值与推荐
- 发现队列FAF1变异:c.1111G>A;p.Asp371Asn,同一家族4例患者携带。
- 验证队列FAF1变异:c.254G>C;p.Arg85Pro。
- 两个变异均编码不稳定FAF1蛋白。
临床怎么用
- 对胚系基础不明的遗传性结直肠癌家族,可考虑FAF1基因变异筛查。
- FAF1变异携带者可能通过凋亡抵抗、β-catenin和NF-κB激活促进结直肠癌发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: A significant proportion of colorectal cancer (CRC) cases have familial aggregation but little is known about the genetic factors that contribute to these cases. We performed an exhaustive functional characterization of genetic variants associated with familial CRC. METHODS: We performed whole-exome sequencing analyses of 75 patients from 40 families with a history of CRC (including early-onset cases) of an unknown germline basis (discovery cohort). We also sequenced specific genes in DNA from an external replication cohort of 473 families, including 488 patients with colorectal tumors that had normal expression of mismatch repair proteins (validation cohort). We disrupted the Fas-associated factor 1 gene (FAF1) in DLD-1 CRC cells using CRISPR/Cas9 gene editing; some cells were transfected with plasmids that express FAF1 missense variants. Cells were analyzed by immunoblots, quantitative real-time polymerase chain reaction, and functional assays monitoring apoptosis, proliferation, and assays for Wnt signaling or nuclear factor (NF)-kappa-B activity. RESULTS: We identified predicted pathogenic variant in the FAF1 gene (c.1111G>A; p.Asp371Asn) in the discovery cohort; it was present in 4 patients of the same family. We identified a second variant in FAF1 in the validation cohort (c.254G>C; p.Arg85Pro). Both variants encoded unstable FAF1 proteins. Expression of these variants in CRC cells caused them to become resistant to apoptosis, accumulate beta-catenin in the cytoplasm, and translocate NF-kappa-B to the nucleus. CONCLUSIONS: In whole-exome sequencing analyses of patients from families with a history of CRC, we identified variants in FAF1 that associate with development of CRC. These variants encode unstable forms of FAF1 that increase resistance of CRC cells to apoptosis and increase activity of beta-catenin and NF-kappa-B.
引用
- Bonjoch L, Franch-Expósito S, Garre P, et al. Germline Mutations in FAF1 Are Associated With Hereditary Colorectal Cancer. Gastroenterology. 2020. PMID: 32179092. doi:10.1053/j.gastro.2020.03.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。